GT Biopharma Inc (GTBP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $7.67M
Last updated: Nov 17, 2026 at 11:02 AM ET
GT Biopharma Inc (GTBP) Earnings: Report Dates and Results
GT Biopharma (GTBP) is expected to report earnings on Mar 1, 2027. In the quarter ended Jun 30, 2026, GT Biopharma reported EPS of -$0.12, below the -$0.08 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
GTBP has an expected report date of Mar 1, 2027.
Earnings History
Of the 22 quarters below that had an estimate, GTBP beat 13 and missed 9. The widest gap in the table came in the quarter ended Mar 31, 2021, when EPS landed 454.55% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$0.12 | -$0.08 | -$0.08 - -$0.08 | -50.00% | Miss | N/A | 1 | 0 up, 0 down | Aug 14, 2026 |
| Mar 31, 2026 | -$0.11 | -$0.08 | -$0.08 - -$0.08 | -37.50% | Miss | N/A | 1 | 0 up, 0 down | May 15, 2026 |
| Dec 31, 2025 | -$121.00 | -$137.50 | N/A | +12.00% | Beat | N/A | 1 | 1 up, 0 down | Mar 2, 2026 |
| Sep 30, 2025 | -$0.83 | -$0.38 | -$0.38 - -$0.38 | -118.42% | Miss | N/A | 1 | 1 up, 0 down | Nov 14, 2025 |
| Jun 30, 2025 | -$0.55 | -$0.68 | N/A | +19.12% | Beat | N/A | N/A | 0 up, 0 down | Aug 14, 2025 |
| Mar 31, 2025 | -$0.76 | -$0.64 | N/A | -18.75% | Miss | N/A | N/A | 0 up, 0 down | May 15, 2025 |
| Dec 31, 2024 | -$1.66 | -$1.55 | N/A | -7.10% | Miss | N/A | N/A | N/A | Feb 21, 2025 |
| Sep 30, 2024 | -$1.53 | -$2.70 | N/A | +43.33% | Beat | N/A | N/A | 0 up, 0 down | Nov 14, 2024 |
| Jun 30, 2024 | -$2.17 | -$2.70 | N/A | +19.74% | Beat | N/A | N/A | 0 up, 0 down | Aug 14, 2024 |
| Mar 31, 2024 | -$1.64 | -$2.70 | -$2.70 - -$2.70 | +39.26% | Beat | N/A | 1 | 0 up, 0 down | Apr 4, 2024 |
| Dec 31, 2023 | -$2.19 | -$2.70 | -$2.70 - -$2.70 | +18.89% | Beat | N/A | 1 | 0 up, 0 down | Mar 26, 2024 |
| Sep 30, 2023 | -$2.13 | -$3.30 | N/A | +35.45% | Beat | N/A | 1 | 0 up, 0 down | Nov 1, 2023 |
| Jun 30, 2023 | -$2.54 | -$3.60 | N/A | +29.44% | Beat | N/A | 2 | 0 up, 0 down | Aug 7, 2023 |
| Mar 31, 2023 | -$2.85 | -$4.35 | -$4.80 - -$3.90 | +34.48% | Beat | N/A | 2 | 0 up, 0 down | May 15, 2023 |
| Dec 31, 2022 | -$0.18 | -$0.17 | -$0.19 - -$0.16 | -5.88% | Miss | N/A | 2 | 0 up, 0 down | Mar 30, 2023 |
| Sep 30, 2022 | -$6.61 | -$3.30 | -$3.30 - -$3.30 | -100.30% | Miss | N/A | 2 | 0 up, 0 down | Oct 31, 2022 |
| Jun 30, 2022 | -$2.86 | -$5.40 | N/A | +47.04% | Beat | N/A | N/A | 0 up, 0 down | Aug 11, 2022 |
| Mar 31, 2022 | -$0.17 | -$0.31 | -$0.47 - -$0.18 | +45.16% | Beat | N/A | 3 | 0 up, 0 down | May 16, 2022 |
| Dec 31, 2021 | -$15.76 | -$6.30 | -$7.21 - -$5.41 | -150.16% | Miss | N/A | 3 | 0 up, 0 down | Mar 28, 2022 |
| Sep 30, 2021 | -$5.69 | -$7.05 | -$9.91 - -$4.20 | +19.29% | Beat | N/A | 3 | N/A | Nov 10, 2021 |
| Jun 30, 2021 | -$3.92 | -$7.65 | N/A | +48.76% | Beat | N/A | N/A | N/A | Aug 23, 2021 |
| Mar 31, 2021 | -$54.90 | -$9.90 | -$9.91 - -$4.80 | -454.55% | Miss | N/A | 2 | N/A | Apr 16, 2021 |
| Dec 31, 2020 | -$3.39 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | Dec 31, 2020 |
| Sep 30, 2020 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 13, 2020 |
| Jun 30, 2020 | -$0.12 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2020 |
| Mar 31, 2020 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 15, 2020 |
| Dec 31, 2019 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 27, 2020 |
| Sep 30, 2019 | -$0.51 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2019 |
| Jun 30, 2019 | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2019 |
| Mar 31, 2019 | -$0.09 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 15, 2019 |
| Dec 31, 2018 | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 29, 2019 |
| Sep 30, 2018 | -$4.70 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 15, 2018 |
| Jun 30, 2018 | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2018 |
| Mar 31, 2018 | -$0.20 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 15, 2018 |
| Dec 31, 2017 | -$0.12 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 1, 2018 |
| Sep 30, 2017 | -$8.15 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2017 |
| Jun 30, 2017 | -$138.55 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 11, 2017 |
| Mar 31, 2017 | -$87.40 | N/A | N/A | N/A | N/A | -585.6% | N/A | N/A | Apr 28, 2017 |
| Dec 31, 2016 | -$448.21 | N/A | N/A | N/A | N/A | -277.9% | N/A | N/A | Mar 31, 2017 |
| Sep 30, 2016 | -$29.41 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2016 |
Estimates made before a stock split are shown on the same share basis as the reported EPS.
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$123.14, after -$7.00 the year before. It was -$499.27 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$123.14 | N/A |
| Dec 31, 2024 | -$7.00 | N/A |
| Dec 31, 2023 | -$9.71 | N/A |
| Dec 31, 2022 | -$9.82 | N/A |
| Dec 31, 2021 | -$80.27 | N/A |
| Dec 31, 2020 | -$3.57 | N/A |
| Dec 31, 2019 | -$0.67 | N/A |
| Dec 31, 2018 | -$5.16 | N/A |
| Dec 31, 2017 | -$234.22 | N/A |
| Dec 31, 2016 | -$499.27 | N/A |
Frequently Asked Questions About GTBP
When is GT Biopharma's next earnings date?
GT Biopharma's next earnings report is expected for Mar 1, 2027.
Did GTBP beat earnings estimates last quarter?
No. GT Biopharma reported EPS of -$0.12 for the quarter ended Jun 30, 2026, below the -$0.08 estimate by 50.00%.
What EPS do analysts expect from GTBP next quarter?
The consensus EPS estimate for GT Biopharma for the quarter ending Dec 31, 2026 is -$2.55 from 3 analysts.
How often does GTBP beat earnings estimates?
GT Biopharma beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -19.66%.
GTBP pages: Overview, Earnings, Forecast, Financials, Competitors